树突状细胞亚群及其功能障碍在肿瘤微环境中的研究进展
Research Progress of Dendritic Cell Subpopulations and Their Dysfunction in the Tumor Microenvironment
DOI: 10.12677/acm.2025.153891, PDF,    国家自然科学基金支持
作者: 白 格*：内蒙古医科大学附属医院第一临床医学院，内蒙古 呼和浩特；高 大#：内蒙古医科大学附属医院血液内科，内蒙古 呼和浩特
关键词: 树突状细胞；树突状细胞亚群；肿瘤微环境；功能障碍；Dendritic Cell； Dendritic Cell Subpopulation； Tumor Microenvironment； Dysfunction
摘要: 树突状细胞(dendritic cells, DCs)是免疫系统专业的抗原呈递细胞(APC)，标志性功能是启动T细胞激活抗原特异性免疫反应。DCs作为宿主免疫应答的关键细胞，在连接先天免疫和适应性免疫之间发挥关键的免疫调控作用。在肿瘤微环境(tumor microenviroment, TME)中，DCs识别肿瘤相关抗原(tumor associated antigen, TAA)是启动和维持有效T细胞介导的抗肿瘤应答的关键起始步骤。大量对肿瘤DCs生物学的研究揭示，由于TME的免疫抑制性及DCs亚群的可塑性，TME中DCs往往功能障碍，并且已经证明这些DCs在抗肿瘤免疫应答中协助肿瘤逃脱免疫监视，促进肿瘤生长。本文介绍DCs的个体生物学、亚群功能及其在TME中功能障碍的机制和可能的治疗靶点。
Abstract: Dendritic cells (DCs) are specialized antigen-presenting cells (APCs) of the immune system, with the characteristic function of initiating T cell activation of antigen-specific immune responses. DCs, as key cells in host immune response, play a crucial role in immune regulation by connecting innate and adaptive immunity. In the tumor microenvironment (TME), DCs recognize tumor-associated antigen (TAA), which is a key initiating step in initiating and maintaining effective T cell-mediated anti-tumor responses. A large amount of research on the biology of tumor DCs has revealed that due to the immunosuppressive properties of TME and the plasticity of DC subpopulations, DCs in TME often function abnormally, and it has been proven that these DCs assist tumors in escaping immune surveillance and promoting tumor growth in anti-tumor immune responses. This article introduces the individual biology, subpopulation functions, and mechanisms of functional impairment of DCs in TME, as well as possible therapeutic targets.
文章引用：白格, 高大. 树突状细胞亚群及其功能障碍在肿瘤微环境中的研究进展[J]. 临床医学进展, 2025, 15(3): 2543-2553. https://doi.org/10.12677/acm.2025.153891

参考文献

[1] De Visser, K.E. and Joyce, J.A. (2023) The Evolving Tumor Microenvironment: From Cancer Initiation to Metastatic Outgrowth. Cancer Cell, 41, 374-403. [Google Scholar] [CrossRef] [PubMed]
[2] Pitt, J.M., Marabelle, A., Eggermont, A., Soria, J.-C., Kroemer, G. and Zitvogel, L. (2016) Targeting the Tumor Microenvironment: Removing Obstruction to Anticancer Immune Responses and Immunotherapy. Annals of Oncology, 27, 1482-1492. [Google Scholar] [CrossRef] [PubMed]
[3] Hubert, M., Gobbini, E., Bendriss-Vermare, N., Caux, C. and Valladeau-Guilemond, J. (2019) Human Tumor-Infiltrating Dendritic Cells: From in Situ Visualization to High-Dimensional Analyses. Cancers, 11, Article 1082. [Google Scholar] [CrossRef] [PubMed]
[4] Wu, R. and Murphy, K.M. (2022) DCs at the Center of Help: Origins and Evolution of the Three-Cell-Type Hypothesis. Journal of Experimental Medicine, 219, e20211519. [Google Scholar] [CrossRef] [PubMed]
[5] Collin, M. and Bigley, V. (2018) Human dendritic cell subsets: an update. Immunology, 154, 3-20. [Google Scholar] [CrossRef] [PubMed]
[6] Macri, C., Pang, E.S., Patton, T. and O’Keeffe, M. (2018) Dendritic Cell Subsets. Seminars in Cell & Developmental Biology, 84, 11-21. [Google Scholar] [CrossRef] [PubMed]
[7] Segura, E. (2022) Human Dendritic Cell Subsets: An Updated View of Their Ontogeny and Functional Specialization. European Journal of Immunology, 52, 1759-1767. [Google Scholar] [CrossRef] [PubMed]
[8] Geissmann, F., Manz, M.G., Jung, S., Sieweke, M.H., Merad, M. and Ley, K. (2010) Development of Monocytes, Macrophages, and Dendritic Cells. Science, 327, 656-661. [Google Scholar] [CrossRef] [PubMed]
[9] Liu, K., Victora, G.D., Schwickert, T.A., Guermonprez, P., Meredith, M.M., Yao, K., et al. (2009) In Vivo Analysis of Dendritic Cell Development and Homeostasis. Science, 324, 392-397. [Google Scholar] [CrossRef] [PubMed]
[10] Gabrilovich, D. (2004) Mechanisms and Functional Significance of Tumour-Induced Dendritic-Cell Defects. Nature Reviews Immunology, 4, 941-952. [Google Scholar] [CrossRef] [PubMed]
[11] Worbs, T., Hammerschmidt, S.I. and Förster, R. (2016) Dendritic Cell Migration in Health and Disease. Nature Reviews Immunology, 17, 30-48. [Google Scholar] [CrossRef] [PubMed]
[12] Bertolini, T.B., Biswas, M., Terhorst, C., Daniell, H., Herzog, R.W. and Piñeros, A.R. (2021) Role of Orally Induced Regulatory T Cells in Immunotherapy and Tolerance. Cellular Immunology, 359, Article ID: 104251. [Google Scholar] [CrossRef] [PubMed]
[13] Del Prete, A., Salvi, V., Soriani, A., Laffranchi, M., Sozio, F., Bosisio, D., et al. (2023) Dendritic Cell Subsets in Cancer Immunity and Tumor Antigen Sensing. Cellular & Molecular Immunology, 20, 432-447. [Google Scholar] [CrossRef] [PubMed]
[14] Lanzavecchia, A. and Sallusto, F. (2001) The Instructive Role of Dendritic Cells on T Cell Responses: Lineages, Plasticity and Kinetics. Current Opinion in Immunology, 13, 291-298. [Google Scholar] [CrossRef] [PubMed]
[15] Kvedaraite, E. and Ginhoux, F. (2022) Human Dendritic Cells in Cancer. Science Immunology, 7, eabm9409. [Google Scholar] [CrossRef] [PubMed]
[16] Marciscano, A.E. and Anandasabapathy, N. (2021) The Role of Dendritic Cells in Cancer and Anti-Tumor Immunity. Seminars in Immunology, 52, Article ID: 101481. [Google Scholar] [CrossRef] [PubMed]
[17] Hubert, M., Gobbini, E., Bendriss-Vermare, N., Caux, C. and Valladeau-Guilemond, J. (2019) Human Tumor-Infiltrating Dendritic Cells: From in Situ Visualization to High-Dimensional Analyses. Cancers, 11, Article 1082. [Google Scholar] [CrossRef] [PubMed]
[18] Peter, S., Charles-Antoine, D., Jinmiao, C., et al. (2017) Mapping the Human DC Lineage through the Integration of High-Dimensional Techniques. Science, 356, eaag3009.
[19] Everts, B., Tussiwand, R., Dreesen, L., Fairfax, K.C., Huang, S.C., Smith, A.M., et al. (2015) Migratory CD103+ Dendritic Cells Suppress Helminth-Driven Type 2 Immunity through Constitutive Expression of IL-12. Journal of Experimental Medicine, 213, 35-51. [Google Scholar] [CrossRef] [PubMed]
[20] Subbiah, V., Murthy, R., Hong, D.S., Prins, R.M., Hosing, C., Hendricks, K., et al. (2018) Cytokines Produced by Dendritic Cells Administered Intratumorally Correlate with Clinical Outcome in Patients with Diverse Cancers. Clinical Cancer Research, 24, 3845-3856. [Google Scholar] [CrossRef] [PubMed]
[21] Böttcher, J.P. and Reis e Sousa, C. (2018) The Role of Type 1 Conventional Dendritic Cells in Cancer Immunity. Trends in Cancer, 4, 784-792. [Google Scholar] [CrossRef] [PubMed]
[22] Hubert, M., Gobbini, E., Couillault, C., Manh, T.V., Doffin, A., Berthet, J., et al. (2020) IFN-III Is Selectively Produced by Cdc1 and Predicts Good Clinical Outcome in Breast Cancer. Science Immunology, 5, eaav3942. [Google Scholar] [CrossRef] [PubMed]
[23] Plesca, I., Müller, L., Böttcher, J.P., Medyouf, H., Wehner, R. and Schmitz, M. (2022) Tumor‐Associated Human Dendritic Cell Subsets: Phenotype, Functional Orientation, and Clinical Relevance. European Journal of Immunology, 52, 1750-1758. [Google Scholar] [CrossRef] [PubMed]
[24] Dutertre, C., Becht, E., Irac, S.E., Khalilnezhad, A., Narang, V., Khalilnezhad, S., et al. (2019) Single-Cell Analysis of Human Mononuclear Phagocytes Reveals Subset-Defining Markers and Identifies Circulating Inflammatory Dendritic Cells. Immunity, 51, 573-589.e8. [Google Scholar] [CrossRef] [PubMed]
[25] Bourdely, P., Anselmi, G., Vaivode, K., Ramos, R.N., Missolo-Koussou, Y., Hidalgo, S., et al. (2020) Transcriptional and Functional Analysis of CD1c+ Human Dendritic Cells Identifies a CD163+ Subset Priming CD8+CD103+ T Cells. Immunity, 53, 335-352.e8. [Google Scholar] [CrossRef] [PubMed]
[26] Rautela, J., Baschuk, N., Slaney, C.Y., Jayatilleke, K.M., Xiao, K., Bidwell, B.N., et al. (2015) Loss of Host Type-I IFN Signaling Accelerates Metastasis and Impairs NK-Cell Antitumor Function in Multiple Models of Breast Cancer. Cancer Immunology Research, 3, 1207-1217. [Google Scholar] [CrossRef] [PubMed]
[27] Zilionis, R., Engblom, C., Pfirschke, C., Savova, V., Zemmour, D., Saatcioglu, H.D., et al. (2019) Single-Cell Transcriptomics of Human and Mouse Lung Cancers Reveals Conserved Myeloid Populations across Individuals and Species. Immunity, 50, 1317-1334.e10. [Google Scholar] [CrossRef] [PubMed]
[28] Gerhard, G.M., Bill, R., Messemaker, M., Klein, A.M. and Pittet, M.J. (2020) Tumor-Infiltrating Dendritic Cell States Are Conserved across Solid Human Cancers. Journal of Experimental Medicine, 218, e20200264. [Google Scholar] [CrossRef] [PubMed]
[29] Cytlak, U., Resteu, A., Pagan, S., Green, K., Milne, P., Maisuria, S., et al. (2020) Differential IRF8 Transcription Factor Requirement Defines Two Pathways of Dendritic Cell Development in Humans. Immunity, 53, 353-370.e8. [Google Scholar] [CrossRef] [PubMed]
[30] Zhang, Q., He, Y., Luo, N., Patel, S.J., Han, Y., Gao, R., et al. (2019) Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma. Cell, 179, 829-845.e20. [Google Scholar] [CrossRef] [PubMed]
[31] Cheng, S., Li, Z., Gao, R., Xing, B., Gao, Y., Yang, Y., et al. (2021) A Pan-Cancer Single-Cell Transcriptional Atlas of Tumor Infiltrating Myeloid Cells. Cell, 184, 792-809.e23. [Google Scholar] [CrossRef] [PubMed]
[32] Zhang, Q., He, Y., Luo, N., Patel, S.J., Han, Y., Gao, R., et al. (2019) Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma. Cell, 179, 829-845.e20. [Google Scholar] [CrossRef] [PubMed]
[33] Rodrigues, P.F., Trsan, T., Cvijetic, G., Khantakova, D., Panda, S.K., Liu, Z., et al. (2024) Progenitors of Distinct Lineages Shape the Diversity of Mature Type 2 Conventional Dendritic Cells. Immunity, 57, 1567-1585.e5. [Google Scholar] [CrossRef] [PubMed]
[34] Musumeci, A., Lutz, K., Winheim, E. and Krug, A.B. (2019) What Makes a pDC: Recent Advances in Understanding Plasmacytoid DC Development and Heterogeneity. Frontiers in Immunology, 10, Article 1222. [Google Scholar] [CrossRef] [PubMed]
[35] Dress, R.J., Dutertre, C., Giladi, A., Schlitzer, A., Low, I., Shadan, N.B., et al. (2019) Plasmacytoid Dendritic Cells Develop from Ly6D+ Lymphoid Progenitors Distinct from the Myeloid Lineage. Nature Immunology, 20, 852-864. [Google Scholar] [CrossRef] [PubMed]
[36] Fuertes, M.B., Kacha, A.K., Kline, J., Woo, S., Kranz, D.M., Murphy, K.M., et al. (2011) Host Type I IFN Signals Are Required for Antitumor CD8+ T Cell Responses through CD8α+ Dendritic Cells. Journal of Experimental Medicine, 208, 2005-2016. [Google Scholar] [CrossRef] [PubMed]
[37] Minohara, K., Imai, M., Matoba, T., Wing, J.B., Shime, H., Odanaka, M., et al. (2023) Mature Dendritic Cells Enriched in Regulatory Molecules May Control Regulatory T Cells and the Prognosis of Head and Neck Cancer. Cancer Science, 114, 1256-1269. [Google Scholar] [CrossRef] [PubMed]
[38] Shen, H., Yang, E.S., Conry, M., Fiveash, J., Contreras, C., Bonner, J.A., et al. (2019) Predictive Biomarkers for Immune Checkpoint Blockade and Opportunities for Combination Therapies. Genes & Diseases, 6, 232-246. [Google Scholar] [CrossRef] [PubMed]
[39] Dixon, K.O., Tabaka, M., Schramm, M.A., Xiao, S., Tang, R., Dionne, D., et al. (2021) TIM-3 Restrains Anti-Tumour Immunity by Regulating Inflammasome Activation. Nature, 595, 101-106. [Google Scholar] [CrossRef] [PubMed]
[40] Chevolet, I., Speeckaert, R., Schreuer, M., Neyns, B., Krysko, O., Bachert, C., et al. (2015) Clinical Significance of Plasmacytoid Dendritic Cells and Myeloid-Derived Suppressor Cells in Melanoma. Journal of Translational Medicine, 13, Article No. 9. [Google Scholar] [CrossRef] [PubMed]
[41] Mazzoccoli, L. and Liu, B. (2024) Dendritic Cells in Shaping Anti-Tumor T Cell Response. Cancers, 16, Article 2211. [Google Scholar] [CrossRef] [PubMed]
[42] Oshi, M., Newman, S., Tokumaru, Y., Yan, L., Matsuyama, R., Kalinski, P., et al. (2020) Plasmacytoid Dendritic Cell (pDC) Infiltration Correlate with Tumor Infiltrating Lymphocytes, Cancer Immunity, and Better Survival in Triple Negative Breast Cancer (TNBC) More Strongly than Conventional Dendritic Cell (cDC). Cancers, 12, Article 3342. [Google Scholar] [CrossRef] [PubMed]
[43] Laheurte, C., Seffar, E., Gravelin, E., Lecuelle, J., Renaudin, A., Boullerot, L., et al. (2022) Interplay between Plasmacytoid Dendritic Cells and Tumor-Specific T Cells in Peripheral Blood Influences Long-Term Survival in Non-Small Cell Lung Carcinoma. Cancer Immunology, Immunotherapy, 72, 579-589. [Google Scholar] [CrossRef] [PubMed]
[44] Min, J., Yang, D., Kim, M., Haam, K., Yoo, A., Choi, J., et al. (2018) Inflammation Induces Two Types of Inflammatory Dendritic Cells in Inflamed Lymph Nodes. Experimental & Molecular Medicine, 50, e458-e458. [Google Scholar] [CrossRef] [PubMed]
[45] Ma, Y., Mattarollo, S.R., Adjemian, S., Yang, H., Aymeric, L., Hannani, D., et al. (2014) CCL2/CCR2-Dependent Recruitment of Functional Antigen-Presenting Cells into Tumors Upon Chemotherapy. Cancer Research, 74, 436-445. [Google Scholar] [CrossRef] [PubMed]
[46] Laoui, D., Keirsse, J., Morias, Y., Van Overmeire, E., Geeraerts, X., Elkrim, Y., et al. (2016) The Tumour Microenvironment Harbours Ontogenically Distinct Dendritic Cell Populations with Opposing Effects on Tumour Immunity. Nature Communications, 7, Article No. 13720. [Google Scholar] [CrossRef] [PubMed]
[47] Ye, Y., Gaugler, B., Mohty, M. and Malard, F. (2020) Plasmacytoid Dendritic Cell Biology and Its Role in Immune‐mediated Diseases. Clinical & Translational Immunology, 9, e1139. [Google Scholar] [CrossRef] [PubMed]
[48] Maier, B., Leader, A.M., Chen, S.T., Tung, N., Chang, C., LeBerichel, J., et al. (2020) Author Correction: A Conserved Dendritic-Cell Regulatory Program Limits Antitumour Immunity. Nature, 582, E17. [Google Scholar] [CrossRef] [PubMed]
[49] Ginhoux, F., Guilliams, M. and Merad, M. (2022) Expanding Dendritic Cell Nomenclature in the Single-Cell Era. Nature Reviews Immunology, 22, 67-68. [Google Scholar] [CrossRef] [PubMed]
[50] Cheng, S., Li, Z., Gao, R., Xing, B., Gao, Y., Yang, Y., et al. (2021) A Pan-Cancer Single-Cell Transcriptional Atlas of Tumor Infiltrating Myeloid Cells. Cell, 184, 792-809.e23. [Google Scholar] [CrossRef] [PubMed]
[51] Zilionis, R., Engblom, C., Pfirschke, C., Savova, V., Zemmour, D., Saatcioglu, H.D., et al. (2019) Single-Cell Transcriptomics of Human and Mouse Lung Cancers Reveals Conserved Myeloid Populations across Individuals and Species. Immunity, 50, 1317-1334.e10. [Google Scholar] [CrossRef] [PubMed]
[52] Maier, B., Leader, A.M., Chen, S.T., Tung, N., Chang, C., LeBerichel, J., et al. (2020) A Conserved Dendritic-Cell Regulatory Program Limits Antitumour Immunity. Nature, 580, 257-262. [Google Scholar] [CrossRef] [PubMed]
[53] Zhang, X., Peng, L., Luo, Y., Zhang, S., Pu, Y., Chen, Y., et al. (2021) Dissecting Esophageal Squamous-Cell Carcinoma Ecosystem by Single-Cell Transcriptomic Analysis. Nature Communications, 12, Article No. 5291. [Google Scholar] [CrossRef] [PubMed]
[54] Tang, M., Diao, J. and Cattral, M.S. (2016) Molecular Mechanisms Involved in Dendritic Cell Dysfunction in Cancer. Cellular and Molecular Life Sciences, 74, 761-776. [Google Scholar] [CrossRef] [PubMed]
[55] Zhu, S., Yang, N., Wu, J., Wang, X., Wang, W., Liu, Y., et al. (2020) Tumor Microenvironment-Related Dendritic Cell Deficiency: A Target to Enhance Tumor Immunotherapy. Pharmacological Research, 159, Article ID: 104980. [Google Scholar] [CrossRef] [PubMed]
[56] Takahashi, A., Kono, K., Ichihara, F., Sugai, H., Fujii, H. and Matsumoto, Y. (2004) Vascular Endothelial Growth Factor Inhibits Maturation of Dendritic Cells Induced by Lipopolysaccharide, but Not by Proinflammatory Cytokines. Cancer Immunology, Immunotherapy, 53, 543-550. [Google Scholar] [CrossRef] [PubMed]
[57] Zelenay, S., van der Veen, A.G., Böttcher, J.P., Snelgrove, K.J., Rogers, N., Acton, S.E., et al. (2015) Cyclooxygenase-dependent Tumor Growth through Evasion of Immunity. Cell, 162, 1257-1270. [Google Scholar] [CrossRef] [PubMed]
[58] Böttcher, J.P., Bonavita, E., Chakravarty, P., Blees, H., Cabeza-Cabrerizo, M., Sammicheli, S., et al. (2018) NK Cells Stimulate Recruitment of CDC1 into the Tumor Microenvironment Promoting Cancer Immune Control. Cell, 172, 1022-1037.e14. [Google Scholar] [CrossRef] [PubMed]
[59] Gao, F., Liu, C., Guo, J., Sun, W., Xian, L., Bai, D., et al. (2015) Radiation-Driven Lipid Accumulation and Dendritic Cell Dysfunction in Cancer. Scientific Reports, 5, Article No. 9613. [Google Scholar] [CrossRef] [PubMed]
[60] Papaspyridonos, M., Matei, I., Huang, Y., do Rosario Andre, M., Brazier-Mitouart, H., Waite, J.C., et al. (2015) Id1 Suppresses Anti-Tumour Immune Responses and Promotes Tumour Progression by Impairing Myeloid Cell Maturation. Nature Communications, 6, Article No. 6840. [Google Scholar] [CrossRef] [PubMed]
[61] Martinez, M., Ono, N., Planutiene, M., Planutis, K., Nelson, E.L. and Holcombe, R.F. (2012) Granulocyte-Macrophage Stimulating Factor (GM-CSF) Increases Circulating Dendritic Cells but Does Not Abrogate Suppression of Adaptive Cellular Immunity in Patients with Metastatic Colorectal Cancer Receiving Chemotherapy. Cancer Cell International, 12, Article No. 2. [Google Scholar] [CrossRef] [PubMed]
[62] Traversari, C., Sozzani, S., Steffensen, K.R. and Russo, V. (2014) LXR‐Dependent and ‐Independent Effects of Oxysterols on Immunity and Tumor Growth. European Journal of Immunology, 44, 1896-1903. [Google Scholar] [CrossRef] [PubMed]
[63] Hodge, D.R., Hurt, E.M. and Farrar, W.L. (2005) The Role of IL-6 and STAT3 in Inflammation and Cancer. European Journal of Cancer, 41, 2502-2512. [Google Scholar] [CrossRef] [PubMed]
[64] Huang, B., Pan, P., Li, Q., Sato, A.I., Levy, D.E., Bromberg, J., et al. (2006) Gr-1+CD115+ Immature Myeloid Suppressor Cells Mediate the Development of Tumor-Induced T Regulatory Cells and T-Cell Anergy in Tumor-Bearing Host. Cancer Research, 66, 1123-1131. [Google Scholar] [CrossRef] [PubMed]
[65] Flies, D.B., Han, X., Higuchi, T., Zheng, L., Sun, J., Ye, J.J., et al. (2014) Coinhibitory Receptor PD-1H Preferentially Suppresses CD4+ T Cell-Mediated Immunity. Journal of Clinical Investigation, 124, 1966-1975. [Google Scholar] [CrossRef] [PubMed]
[66] Munn, D.H. and Mellor, A.L. (2016) IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance. Trends in Immunology, 37, 193-207. [Google Scholar] [CrossRef] [PubMed]
[67] Garris, C.S., Arlauckas, S.P., Kohler, R.H., Trefny, M.P., Garren, S., Piot, C., et al. (2022) Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12. Immunity, 55, 1749. [Google Scholar] [CrossRef] [PubMed]
[68] Neophytou, C.M., Pierides, C., Christodoulou, M., Costeas, P., Kyriakou, T. and Papageorgis, P. (2020) The Role of Tumor-Associated Myeloid Cells in Modulating Cancer Therapy. Frontiers in Oncology, 10, Article 899. [Google Scholar] [CrossRef] [PubMed]
[69] Steinbrink, K., Jonuleit, H., Müller, G., Schuler, G., Knop, J. and Enk, A.H. (1999) Interleukin-10-Treated Human Dendritic Cells Induce a Melanoma-Antigen-Specific Anergy in CD8+ T Cells Resulting in a Failure to Lyse Tumor Cells. Blood, 93, 1634-1642. [Google Scholar] [CrossRef] 
[70] Ren, Y., Yang, J., Sun, R., Zhang, L., Zhao, L., Li, B., et al. (2016) Viral IL-10 Down-Regulates the “MHC-I Antigen Processing Operon” through the NF-ΚB Signaling Pathway in Nasopharyngeal Carcinoma Cells. Cytotechnology, 68, 2625-2636. [Google Scholar] [CrossRef] [PubMed]
[71] Terra, M., Oberkampf, M., Fayolle, C., Rosenbaum, P., Guillerey, C., Dadaglio, G., et al. (2018) Tumor-Derived TGfβ Alters the Ability of Plasmacytoid Dendritic Cells to Respond to Innate Immune Signaling. Cancer Research, 78, 3014-3026. [Google Scholar] [CrossRef] [PubMed]
[72] Morante-Palacios, O., Fondelli, F., Ballestar, E. and Martínez-Cáceres, E.M. (2021) Tolerogenic Dendritic Cells in Autoimmunity and Inflammatory Diseases. Trends in Immunology, 42, 59-75. [Google Scholar] [CrossRef] [PubMed]
[73] Fucikova, J., Palova-Jelinkova, L., Bartunkova, J. and Spisek, R. (2019) Induction of Tolerance and Immunity by Dendritic Cells: Mechanisms and Clinical Applications. Frontiers in Immunology, 10, Article 2393. [Google Scholar] [CrossRef] [PubMed]
[74] Sage, P.T., Schildberg, F.A., Sobel, R.A., Kuchroo, V.K., Freeman, G.J. and Sharpe, A.H. (2018) Dendritic Cell PD-L1 Limits Autoimmunity and Follicular T Cell Differentiation and Function. The Journal of Immunology, 200, 2592-2602. [Google Scholar] [CrossRef] [PubMed]

为你推荐